Evidence map›Paper›PMID 27542389›Full record

ArticlePathogens and disease2016

Role of epigenetics in modulation of immune response at the junction of host-pathogen interaction and danger molecule signaling.

Ana Carolina Morandini, Carlos F Santos, Özlem Yilmaz

Open access · bronzeAbstract read
In one paragraph

Article in Pathogens and disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. A Palearctic view of a bat fungal disease.Conservation biology : the journal of the Society for Conservation Biology · 2025
    Review
  6. Article
  7. Article
  8. Immune Homeostasis: A Novel Example of Teamwork.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Why do insects evolve immune priming? A search for crossroads.Developmental and comparative immunology · 2022
    Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ana Carolina MorandiniDepartment of Biological Sciences, Bauru School of Dentistry - University of São Paulo, Bauru, SP, Brazil Department of Biomedical Sciences, University of the Pacific, Arthur Dugoni School of Dentistry, San Francisco, CA 94103, USA Department of Oral Health Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, SC 29425, USA amorandini@pacific.edu yilmaz@musc.edu.
Carlos F SantosDepartment of Biological Sciences, Bauru School of Dentistry - University of São Paulo, Bauru, SP, Brazil.
Özlem YilmazDepartment of Oral Health Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, SC 29425, USA Department of Microbiology and Immunology, College of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA amorandini@pacific.edu yilmaz@musc.edu.
Medical University of South Carolina · USUniversidade de São Paulo · BR

Funding

Modulation of epithelial cell response by P. gingivalisR01DE016593 · NIDCR · UNIVERSITY OF FLORIDA · PI YILMAZ, OZLEM · 2006 to 2016
$3.3M
Modulation of Epithelial Cell Response by P. gingivalisR56DE016593 · NIDCR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI YILMAZ, OZLEM · 2019 to 2019
$355k
NIDCR NIH HHS R01 DE016593NIDCR NIH HHS R56 DE016593
6 · The paper itself

Abstract

Epigenetic mechanisms have rapidly and controversially emerged as silent modulators of host defenses that can lead to a more prominent immune response and shape the course of inflammation in the host. Thus, the epigenetics can both drive the production of specific inflammatory mediators and control the magnitude of the host response. The epigenetic actions that are predominantly shown to modulate the host defense against microbial pathogens are DNA methylation, histone modification and the activity of non-coding RNAs. There is also growing evidence that opportunistic chronic pathogens, such as Porphyromonas gingivalis, as a microbial host subversion strategy, can epigenetically interfere with the host DNA machinery for successful colonization. Similarly, the novel involvement of small molecule 'danger signals', which are released by stressed or infected cells, at the center of host-pathogen interplay and epigenetics is developing. In this review, we systematically examine the latest knowledge within the field of epigenetics in the context of host-derived danger molecule and purinergic signaling, with a particular focus on host microbial defenses and infection-driven chronic inflammation.

Indexed as

danger molecule signalingDNA methylationepigeneticshistone deacetylationinnate immunityopportunistic bacteria

Identifiers

PMID27542389
PMCPMC5985482
OpenAlexW2514730264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.